Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults

Cohorts of healthy younger adults (18–50yrs) and healthy older adults (60–75yrs) were immunized intramuscularly or intranasally with an adenovirus-vectored RSV vaccine (PanAd3-RSV) as a prime dose and boosted with PanAd3-RSV or a poxvirus-vectored vaccine (MVA-RSV) encoding the same insert. Whole bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, C, McGinley, J, Sande, C, Capone, S, Makvandi-Nejad, S, Vitelli, A, Silva-Reyes, L, Bibi, S, Otasowie, C, Sheerin, D, Thompson, A, Dold, C, Klenerman, P, Barnes, E, Dorrell, L, Rollier, C, Pollard, A, O’Connor, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Vaccine Development
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038321/
https://www.ncbi.nlm.nih.gov/pubmed/36622786
http://dx.doi.org/10.1093/cei/uxad003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038321/
https://www.ncbi.nlm.nih.gov/pubmed/36622786
http://dx.doi.org/10.1093/cei/uxad003

Ejemplares similares